<DOC>
	<DOCNO>NCT00745004</DOCNO>
	<brief_summary>Irritable bowel syndrome common condition affect 1 10 population . About third suffer diarrhoea , severely impairs quality life . Previous study Nottingham suggest patient diarrhoea may excess chemical call serotonin gut . Serotonin stimulate secretion propulsion gut contribute diarrhoea . We interested see whether drug , Ondansetron , block effect serotonin , would improve symptom patient IBS diarrhoea . We think drug may work good people specific gene type genetic makeup may influence would like test . Because IBS symptom fluctuate , one way determine whether Ondansetron effective perform randomise placebo control trial neither patient doctor know medication take part study .</brief_summary>
	<brief_title>Ondansetron Treatment IBS With Diarrhoea ( IBS-D )</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>IBSD patient meet Rome III criterion . Male female age 1875 year Women child bear potential ( negative pregnancy test ) must agree use method medically acceptable form contraception study. , ( e.g . implant , injectables , combine oral contraceptive , sexual abstinence vasectomise partner ) Patients able give inform consent . Women pregnant breastfeeding Patients , opinion investigator , consider unsuitable . Patients abdominal surgery may cause bowel symptom similar IBS ( Please note , appendicectomy cholecystectomy exclusion ) Patient unable stop antidiarrhoeal drug Patients currently participate another clinical trial trial previous three month Since many patient SSRIs tricyclic antidepressant exclusion criterion , provide medication least 3 month dose remains unaltered throughout study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>IBS D</keyword>
</DOC>